Intracameral Versus Intravitreal Bevacizumab Injection in NVG: RCT

Clinical trial NCT03648814 · RECRUITING

Trial details

NCT number: NCT03648814
Sponsor: Prince of Songkla University
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Glaucoma, Neovascular Vascular Endothelial Growth Factor Overexpression

Start date: 2018-08-01
Primary completion: 2026-07-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.